Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial
Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found...
Gespeichert in:
Veröffentlicht in: | Psycho-oncology (Chichester, England) England), 2004-11, Vol.13 (11), p.818-830 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 830 |
---|---|
container_issue | 11 |
container_start_page | 818 |
container_title | Psycho-oncology (Chichester, England) |
container_volume | 13 |
creator | Given, Charles Given, Barbara Rahbar, Mohammad Jeon, Sangchoon McCorkle, Ruth Cimprich, Bernadine Galecki, Andrez Kozachik, Sharon Devoss, Danielle Brady, Albert Fisher-Malloy, Mary Jo Courtney, Kathy Bowie, Elizabeth |
description | Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/pon.807 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_764236028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67096295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</originalsourceid><addsrcrecordid>eNqF0dFqFDEUBuAgiq2r-AYSvNALmXqSySQzvZNq19KyLaJ4GbKZMyV1JjMmGXXfvll3sVBQr3IIHz85-Ql5zuCIAfC30-iPalAPyCGDpimYZOzhdq5U0XDRHJAnMd4AZNvIx-SAVWUtVQOHZHg_YqSGxs0wpXGgg_HmGgf0iTqfMPzIkxs9NV2HNtEWp4Ax_r4ZRn9NrfEWA51MclnGY_oJ49ynSLuQ0wy1vfPOmp6m4Ez_lDzqTB_x2f5ckC-nHz6ffCwuLpdnJ-8uCisEU4WRohUt46WFzioLFedWtYLLuuKAsK6xKVsQDeuAl0JAVWPLuYGKSaHkWpYL8nqXO4Xx-4wx6cFFi31vPI5z1EoKXkrgdZav_imlyj_Gm-q_sFKsZtvYBXl5D96Mc_B5Xc05V7IEUd890IYxxoCdnoIbTNhoBnrbqM6N6txoli_2cfN6wPbO7SvM4M0O_HQ9bv6Wo68uV7u4YqddTPjrjzbhW161VJX-ulpqJa7Y8vx8pVV5C5T_t3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222763048</pqid></control><display><type>article</type><title>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</title><source>MEDLINE</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Wiley Online Library All Journals</source><creator>Given, Charles ; Given, Barbara ; Rahbar, Mohammad ; Jeon, Sangchoon ; McCorkle, Ruth ; Cimprich, Bernadine ; Galecki, Andrez ; Kozachik, Sharon ; Devoss, Danielle ; Brady, Albert ; Fisher-Malloy, Mary Jo ; Courtney, Kathy ; Bowie, Elizabeth</creator><creatorcontrib>Given, Charles ; Given, Barbara ; Rahbar, Mohammad ; Jeon, Sangchoon ; McCorkle, Ruth ; Cimprich, Bernadine ; Galecki, Andrez ; Kozachik, Sharon ; Devoss, Danielle ; Brady, Albert ; Fisher-Malloy, Mary Jo ; Courtney, Kathy ; Bowie, Elizabeth</creatorcontrib><description>Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1057-9249</identifier><identifier>EISSN: 1099-1611</identifier><identifier>DOI: 10.1002/pon.807</identifier><identifier>PMID: 15386790</identifier><identifier>CODEN: POJCEE</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Adult ; Antineoplastic Agents - therapeutic use ; Cancer ; Chemotherapy ; Clinical outcomes ; Clinical trials ; Cognitive behaviour therapy ; Cognitive Therapy - methods ; Depression ; Depressive Disorder, Major - diagnosis ; Depressive Disorder, Major - epidemiology ; Female ; Humans ; Intervention ; Male ; Mental depression ; Neoplasms - drug therapy ; Neoplasms - epidemiology ; Neoplasms - psychology ; Neoplasms - therapy ; Patients ; Reduction ; USA</subject><ispartof>Psycho-oncology (Chichester, England), 2004-11, Vol.13 (11), p.818-830</ispartof><rights>Copyright © 2004 John Wiley & Sons, Ltd.</rights><rights>Copyright (c) 2004 John Wiley & Sons, Ltd.</rights><rights>Copyright John Wiley and Sons, Limited Nov 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</citedby><cites>FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpon.807$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpon.807$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,30999,31000,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15386790$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Given, Charles</creatorcontrib><creatorcontrib>Given, Barbara</creatorcontrib><creatorcontrib>Rahbar, Mohammad</creatorcontrib><creatorcontrib>Jeon, Sangchoon</creatorcontrib><creatorcontrib>McCorkle, Ruth</creatorcontrib><creatorcontrib>Cimprich, Bernadine</creatorcontrib><creatorcontrib>Galecki, Andrez</creatorcontrib><creatorcontrib>Kozachik, Sharon</creatorcontrib><creatorcontrib>Devoss, Danielle</creatorcontrib><creatorcontrib>Brady, Albert</creatorcontrib><creatorcontrib>Fisher-Malloy, Mary Jo</creatorcontrib><creatorcontrib>Courtney, Kathy</creatorcontrib><creatorcontrib>Bowie, Elizabeth</creatorcontrib><title>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</title><title>Psycho-oncology (Chichester, England)</title><addtitle>Psycho-Oncology</addtitle><description>Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley & Sons, Ltd.</description><subject>Adult</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Clinical outcomes</subject><subject>Clinical trials</subject><subject>Cognitive behaviour therapy</subject><subject>Cognitive Therapy - methods</subject><subject>Depression</subject><subject>Depressive Disorder, Major - diagnosis</subject><subject>Depressive Disorder, Major - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Intervention</subject><subject>Male</subject><subject>Mental depression</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - psychology</subject><subject>Neoplasms - therapy</subject><subject>Patients</subject><subject>Reduction</subject><subject>USA</subject><issn>1057-9249</issn><issn>1099-1611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqF0dFqFDEUBuAgiq2r-AYSvNALmXqSySQzvZNq19KyLaJ4GbKZMyV1JjMmGXXfvll3sVBQr3IIHz85-Ql5zuCIAfC30-iPalAPyCGDpimYZOzhdq5U0XDRHJAnMd4AZNvIx-SAVWUtVQOHZHg_YqSGxs0wpXGgg_HmGgf0iTqfMPzIkxs9NV2HNtEWp4Ax_r4ZRn9NrfEWA51MclnGY_oJ49ynSLuQ0wy1vfPOmp6m4Ez_lDzqTB_x2f5ckC-nHz6ffCwuLpdnJ-8uCisEU4WRohUt46WFzioLFedWtYLLuuKAsK6xKVsQDeuAl0JAVWPLuYGKSaHkWpYL8nqXO4Xx-4wx6cFFi31vPI5z1EoKXkrgdZav_imlyj_Gm-q_sFKsZtvYBXl5D96Mc_B5Xc05V7IEUd890IYxxoCdnoIbTNhoBnrbqM6N6txoli_2cfN6wPbO7SvM4M0O_HQ9bv6Wo68uV7u4YqddTPjrjzbhW161VJX-ulpqJa7Y8vx8pVV5C5T_t3w</recordid><startdate>200411</startdate><enddate>200411</enddate><creator>Given, Charles</creator><creator>Given, Barbara</creator><creator>Rahbar, Mohammad</creator><creator>Jeon, Sangchoon</creator><creator>McCorkle, Ruth</creator><creator>Cimprich, Bernadine</creator><creator>Galecki, Andrez</creator><creator>Kozachik, Sharon</creator><creator>Devoss, Danielle</creator><creator>Brady, Albert</creator><creator>Fisher-Malloy, Mary Jo</creator><creator>Courtney, Kathy</creator><creator>Bowie, Elizabeth</creator><general>John Wiley & Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200411</creationdate><title>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</title><author>Given, Charles ; Given, Barbara ; Rahbar, Mohammad ; Jeon, Sangchoon ; McCorkle, Ruth ; Cimprich, Bernadine ; Galecki, Andrez ; Kozachik, Sharon ; Devoss, Danielle ; Brady, Albert ; Fisher-Malloy, Mary Jo ; Courtney, Kathy ; Bowie, Elizabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Clinical outcomes</topic><topic>Clinical trials</topic><topic>Cognitive behaviour therapy</topic><topic>Cognitive Therapy - methods</topic><topic>Depression</topic><topic>Depressive Disorder, Major - diagnosis</topic><topic>Depressive Disorder, Major - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Intervention</topic><topic>Male</topic><topic>Mental depression</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - psychology</topic><topic>Neoplasms - therapy</topic><topic>Patients</topic><topic>Reduction</topic><topic>USA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Given, Charles</creatorcontrib><creatorcontrib>Given, Barbara</creatorcontrib><creatorcontrib>Rahbar, Mohammad</creatorcontrib><creatorcontrib>Jeon, Sangchoon</creatorcontrib><creatorcontrib>McCorkle, Ruth</creatorcontrib><creatorcontrib>Cimprich, Bernadine</creatorcontrib><creatorcontrib>Galecki, Andrez</creatorcontrib><creatorcontrib>Kozachik, Sharon</creatorcontrib><creatorcontrib>Devoss, Danielle</creatorcontrib><creatorcontrib>Brady, Albert</creatorcontrib><creatorcontrib>Fisher-Malloy, Mary Jo</creatorcontrib><creatorcontrib>Courtney, Kathy</creatorcontrib><creatorcontrib>Bowie, Elizabeth</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Psycho-oncology (Chichester, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Given, Charles</au><au>Given, Barbara</au><au>Rahbar, Mohammad</au><au>Jeon, Sangchoon</au><au>McCorkle, Ruth</au><au>Cimprich, Bernadine</au><au>Galecki, Andrez</au><au>Kozachik, Sharon</au><au>Devoss, Danielle</au><au>Brady, Albert</au><au>Fisher-Malloy, Mary Jo</au><au>Courtney, Kathy</au><au>Bowie, Elizabeth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</atitle><jtitle>Psycho-oncology (Chichester, England)</jtitle><addtitle>Psycho-Oncology</addtitle><date>2004-11</date><risdate>2004</risdate><volume>13</volume><issue>11</issue><spage>818</spage><epage>830</epage><pages>818-830</pages><issn>1057-9249</issn><eissn>1099-1611</eissn><coden>POJCEE</coden><abstract>Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>15386790</pmid><doi>10.1002/pon.807</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1057-9249 |
ispartof | Psycho-oncology (Chichester, England), 2004-11, Vol.13 (11), p.818-830 |
issn | 1057-9249 1099-1611 |
language | eng |
recordid | cdi_proquest_miscellaneous_764236028 |
source | MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Wiley Online Library All Journals |
subjects | Adult Antineoplastic Agents - therapeutic use Cancer Chemotherapy Clinical outcomes Clinical trials Cognitive behaviour therapy Cognitive Therapy - methods Depression Depressive Disorder, Major - diagnosis Depressive Disorder, Major - epidemiology Female Humans Intervention Male Mental depression Neoplasms - drug therapy Neoplasms - epidemiology Neoplasms - psychology Neoplasms - therapy Patients Reduction USA |
title | Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A46%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20a%20symptom%20management%20intervention%20affect%20depression%20among%20cancer%20patients:%20Results%20from%20a%20clinical%20trial&rft.jtitle=Psycho-oncology%20(Chichester,%20England)&rft.au=Given,%20Charles&rft.date=2004-11&rft.volume=13&rft.issue=11&rft.spage=818&rft.epage=830&rft.pages=818-830&rft.issn=1057-9249&rft.eissn=1099-1611&rft.coden=POJCEE&rft_id=info:doi/10.1002/pon.807&rft_dat=%3Cproquest_cross%3E67096295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222763048&rft_id=info:pmid/15386790&rfr_iscdi=true |